We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Towards a patient-driven approach to adverse events of targeted agents in oncology
ThesesMedical Sciences

Towards a patient-driven approach to adverse events of targeted agents in oncology

Checking your access to this record.

Abstract & Overview

This thesis presents three notable findings: the voice of\n the patient is inconsequently incorporated in scientific research regarding\n adverse events; available instruments may be of limited value for approaching\n targeted therapy-associated mucocutaneous adverse events; and available\n knowledge about a patient-driven approach to adverse events is not broadly\n incorporated in research and clinical care.\n The voice of the patient is inconsequently incorporated in scientific\n research and the healthcare-professional plays the central role in adverse\n event diagnosis and management. The incidence of the adverse events is mainly\n measured by healthcare-professionals with suboptimal scales. As a result\n there may be underreporting of adverse events. In addition, the non-validated\n CTCAE scoring system for the grading of the adverse events is most commonly\n used while more precise grading instruments are available. Currently, most adverse\n events grading is performed by healthcare-professionals rather than by\n patients.\n The work in this thesis lead to recommendations to develop collaboration with\n patients. The conceptual co-care model of a patient-driven approach to\n adverse events of targeted agents in oncology may be complemented with a\n 3-part adverse event assessment and grading instrument, evidence based\n adverse event treatment guidelines, and obligated educational programs on the\n adverse events core competencies, and applied.

Cite this record

C. Boers (2019). Towards a patient-driven approach to adverse events of targeted agents in oncology. Thesis, Royal Netherlands Academy of Arts and Sciences. https://library.shubhaarti.com/content/b7075d1a-9270-46c1-9e19-fbb163186625

Copy in another style

Boers, C. (2019). Towards a patient-driven approach to adverse events of targeted agents in oncology. Thesis, Royal Netherlands Academy of Arts and Sciences. https://library.shubhaarti.com/content/b7075d1a-9270-46c1-9e19-fbb163186625
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.